1. Kahraman, A., E. Mutlu and M. Aldag, 2017. ADMA, SDMA and L-arginine may be novel targets in pharmacotherapy for complications due to cardiopulmonary bypass. J. Med. Biochem., 36: 8-17.
   CrossRef  |  Direct Link  |  
2. Mutlu, E., S. Ilhan, E. Onat, M. Kara and E. Sahna, 2016. The effects of novokinin, an AT2 agonist, on blood pressure, vascular responses and levels of ADMA, NADPH oxidase and Rho kinase in hypertension induced by NOS inhibition and salt. Turk. J. Med. Sci., 46: 1249-1257.
   Direct Link  |  
3. Kunak, C.S., O. Kukula, E. Mutlu, F. Genc and G.G. Peker et al., 2015. The effect of etoricoxib on hepatic ischemia-reperfusion injury in rats. Oxid. Med. Cell. Longevity, Vol. 2015. 10.1155/2015/598162.
   CrossRef  |  Direct Link  |  
4. Ilkaya, F., M. Yuce, A.E. Agri, H. Guzel and H. Balci et al., 2015. The combination of agomelatine and ritanserin exerts a synergistic interaction in passive avoidance task. Hum. Exp. Toxicol., 34: 787-795.
   CrossRef  |  Direct Link  |